TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization.
Zhao K, Karimi A, Kelly L, Petre E, Marinelli B, Alexander ES, Sotirchos VS, Erinjeri JP, Covey A, Sofocleous CT, Harding JJ, Jarnagin W, Sigel C, Vakiani E, Ziv E, Yarmohammadi H.
Zhao K, et al. Among authors: yarmohammadi h.
Curr Oncol. 2025 Jan 18;32(1):51. doi: 10.3390/curroncol32010051.
Curr Oncol. 2025.
PMID: 39851967